180 related articles for article (PubMed ID: 25996654)
21. Developing diagnostic criteria in Waldenstrom's macroglobulinemia.
Owen RG
Semin Oncol; 2003 Apr; 30(2):196-200. PubMed ID: 12720135
[TBL] [Abstract][Full Text] [Related]
22. Waldenström's macroglobulinemia developing in a patient with multiple sclerosis: coincidence or association?
Deftereos S; Farmakis D; Papadogianni A; Besleme B; Diamanti-Kandarakis E; Polymeropoylos E; Georgonikou D; Aessopos A
Mult Scler; 2004 Oct; 10(5):598-600. PubMed ID: 15471380
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Owen RG; Treon SP; Al-Katib A; Fonseca R; Greipp PR; McMaster ML; Morra E; Pangalis GA; San Miguel JF; Branagan AR; Dimopoulos MA
Semin Oncol; 2003 Apr; 30(2):110-5. PubMed ID: 12720118
[TBL] [Abstract][Full Text] [Related]
24. Does Waldenstrom's macroglobulinemia also cause bone destruction? A rare case report.
Lin JM; Yuan XJ; Zhang L; Li G; Gan XR; Xu WH
J Int Med Res; 2022 Apr; 50(4):3000605221096161. PubMed ID: 35485877
[TBL] [Abstract][Full Text] [Related]
25. Unusual evolution of Waldenström's macroglobulinemia into osteolytic myeloma.
Jondeau K; Alterescu R; Franc B; Davi F; Massé JM; Boukour S; Le Parc JM; Cramer EM
Eur J Haematol; 2006 Jul; 77(1):74-9. PubMed ID: 16827885
[TBL] [Abstract][Full Text] [Related]
26. [IgM Myeloma: case report and literature review].
Labrousse J; Plasse F; Aucher P; Augereau P; Bertin A; Carrere F; Cognée AS; Vignon G; Violette J; Lellouche F
Ann Biol Clin (Paris); 2018 Oct; 76(5):575-578. PubMed ID: 30226197
[TBL] [Abstract][Full Text] [Related]
27. [IgM multiple myeloma].
Calvo Villas J; Ramírez Sánchez M; Sicilia Guillén F
Sangre (Barc); 1997 Jun; 42(3):257-8. PubMed ID: 9381279
[No Abstract] [Full Text] [Related]
28. Challenging diagnosis of IgM multiple myeloma.
Mahmood F; Ahmed B; Thalody V; Mehdi S
BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38176750
[TBL] [Abstract][Full Text] [Related]
29. IgM Myeloma with Plasma Cell Leukemia: Case Report and Literature Review.
Chhabra S; Jain S; Fowler A; Sedov V; Neppalli AK; Schandl CA; Lazarchick J
Ann Clin Lab Sci; 2017 Sep; 47(5):611-619. PubMed ID: 29066491
[TBL] [Abstract][Full Text] [Related]
30. Guideline for diagnosis and treatment of Waldenström's macroglobulinaemia.
Vos JM; Minnema MC; Wijermans PW; Croockewit S; Chamuleau ME; Pals ST; Klein SK; Delforge M; van Imhoff GW; Kersten MJ; ;
Neth J Med; 2013 Mar; 71(2):54-62. PubMed ID: 23462052
[TBL] [Abstract][Full Text] [Related]
31. Clinical characteristics and factors predicting evolution of asymptomatic IgM monoclonal gammopathies and IgM-related disorders.
Morra E; Cesana C; Klersy C; Barbarano L; Varettoni M; Cavanna L; Canesi B; Tresoldi E; Miqueleiz S; Bernuzzi P; Nosari AM; Lazzarino M
Leukemia; 2004 Sep; 18(9):1512-7. PubMed ID: 15322559
[TBL] [Abstract][Full Text] [Related]
32. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
Treon SP; Xu L; Yang G; Zhou Y; Liu X; Cao Y; Sheehy P; Manning RJ; Patterson CJ; Tripsas C; Arcaini L; Pinkus GS; Rodig SJ; Sohani AR; Harris NL; Laramie JM; Skifter DA; Lincoln SE; Hunter ZR
N Engl J Med; 2012 Aug; 367(9):826-33. PubMed ID: 22931316
[TBL] [Abstract][Full Text] [Related]
33. IgM multiple myeloma: a diagnostic challenge in a patient with coexisting chronic lymphocytic leukaemia.
Hewamana S; Pepper C; Couzens S; Thomas A; Knapper S
Int J Hematol; 2008 Nov; 88(4):424-427. PubMed ID: 18846322
[TBL] [Abstract][Full Text] [Related]
34. Waldenstrom macroglobulinemia presenting with pancreatic mass: a case report and review of literature.
Nayak HK; Kar P; Bagchi A; Kapoor N; Kapahtia S; Sonika U; Kumar N; Kumar S
JOP; 2013 Jan; 14(1):92-5. PubMed ID: 23306344
[TBL] [Abstract][Full Text] [Related]
35. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.
Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S
Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376
[TBL] [Abstract][Full Text] [Related]
36. 16q23/MAF Gene Deletion Is a Frequent Cytogenetic Abnormality in Multiple Myeloma Associated With IgH Deletion but Significantly Lower Incidence of High-Risk Translocations.
Rana S; Sreedharanunni S; Panakkal V; Singh Sachdeva MU; Varma N; Malhotra P
Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):e398-e401. PubMed ID: 33309247
[No Abstract] [Full Text] [Related]
37. Assessment of bone marrow response in Waldenström's macroglobulinemia.
Varghese AM; Rawstron AC; Ashcroft AJ; Moreton P; Owen RG
Clin Lymphoma Myeloma; 2009 Mar; 9(1):53-5. PubMed ID: 19362973
[TBL] [Abstract][Full Text] [Related]
38. Concomitant Waldenstrom macroglobulinemia and IgA plasmablastic myeloma in a patient with untreated IgM paraproteinemia: sequential development of biclonal B-cell neoplasms over a 10-year period in a single individual.
Wang E; Kulbacki E; Stoecker M
Hum Pathol; 2012 Jul; 43(7):1135-41. PubMed ID: 22404949
[TBL] [Abstract][Full Text] [Related]
39. Combinations of cytogenetics and international scoring system can predict poor prognosis in multiple myeloma after high-dose chemotherapy and autologous stem cell transplantation.
Inamoto Y; Kurahashi S; Imahashi N; Fukushima N; Adachi T; Kinoshita T; Tsushita K; Miyamura K; Naoe T; Sugiura I
Am J Hematol; 2009 May; 84(5):283-6. PubMed ID: 19338045
[TBL] [Abstract][Full Text] [Related]
40. Value of serum viscosity measurements in assessing the response to therapy in myeloma and Waldenström's macroglobulinaemia.
Kok DA
Bibl Anat; 1967; 9():252-8. PubMed ID: 4961775
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
